Structure of Ebola Virus Protein Determined
Posted by SR in News, tags: structure, virology
Ebola virus, named after a river in the Democratic Republic of the Congo where it was first identified, causes a severe, often fatal haemorrhagic fever. There is no vaccine against or specific treatment for Ebola virus infection, but researchers at Iowa State University have now moved a step closer to finding a treatment. Using a combination of X-ray crystallography and nuclear magnetic resonance spectroscopy, the group has succeeded in determining the structure of a key portion of the viral protein, VP35, at a resolution of 1.4 Å. The Ebola VP35 protein forms part of the viral RNA polymerase complex, acts as a viral assembly factor, and also inhibits production of host interferon.
Binding of VP35 to dsRNA correlates with suppression of interferon activity and viral virulence, and the group hopes that the new structure of the interferon inhibitory domain will allow them to design drugs that bind to VP35 and block its function. The protein forms a unique fold with two clusters of basic residues, one of which is important for dsRNA binding and inhibition of interferon production. The study is published in the January 13th issue of PNAS.
Related posts:
- NS1 Protein ‘Hides’ Influenza Virus RNA The non-structural (NS1) protein of influenza A viruses plays a major role in countering host immune defence by limiting production...
- Structure of Aromatase Determined The majority (75-80%) of breast cancers are hormone-sensitive and their growth is stimulated by the hormones estrogen and progesterone. In...
- Virus-like Particles Protect against Chikungunya Virus Infection. Chikungunya is a viral disease spread by mosquitoes which causes fever and severe joint pain – the name derives from...
- Small Molecule Inhibitors of Kaposi’s Sarcoma Virus Protease Kaposi’s sarcoma (KS) is caused by Kaposi sarcoma herpes virus (KSHV) which is also known as human herpes virus 8...
- First Interferon-free Oral Combination Study for HCV In total, around 200million people are thought to be infected hepatitis C virus (HCV). The current standard of care treatment...
Related posts brought to you by Yet Another Related Posts Plugin.
This entry was posted on Friday, January 16th, 2009 at 8:18 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.


















Entries (RSS)
There is a specific treatment in the pipeline for Ebola and Marburg viruses. See the article in the link below for some early systemic in vivo animal model work. Human trials are more difficult as you can imagine. (e.g. human outbreaks are sporadic and small.)
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1326218